OptimizeRx Net Income

The latest net income for OPRX is $4.6M as of June 2026. That compares with $-9.9M in the prior-year period — up 146.6% year over year. That is below the Healthcare sector average of $17B. Investors often review this figure alongside OptimizeRx's historical trend and sector peers before judging valuation or financial health.

Over the past year, OPRX's net income moved from $-9.9M to $4.6M — a 146.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in OptimizeRx's operating scale or balance-sheet position.

Against Healthcare companies, OPRX currently prints $4.6M for net income, while the sector average sits near $17B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at OptimizeRx's growth, margins, and balance sheet.

A net income figure of $4.6M for OPRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $17B. Explore the charts below for those layers of context.

After noting OPRX's net income ($4.6M), review year-over-year change from $-9.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.